Evidence map›Paper›PMID 29273639›Full record

ArticleJournal of the American Heart Association2017

Adverse Effects on β-Adrenergic Receptor Coupling: Ischemic Postconditioning Failed to Preserve Long-Term Cardiac Function.

Rolf Schreckenberg, Péter Bencsik, Martin Weber, Yaser Abdallah, Csaba Csonka, Kamilla Gömöri, Krisztina Kiss, János Pálóczi, Judit Pipis, Márta Sárközy and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. p53 and the E3 Ubiquitin Ligase MDM2 in Glaucomatous Lamina Cribrosa Cells.International journal of molecular sciences · 2024
    Article
  2. p53 and Myofibroblast Apoptosis in Organ Fibrosis.International journal of molecular sciences · 2023
    Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Rolf SchreckenbergPhysiologisches Institut, Justus-Liebig-Universität Gießen, Gießen, Germany rolf.schreckenberg@physiologie.med.uni-giessen.de.
Péter BencsikPharmahungary Group, Szeged, Hungary.
Martin WeberPhysiologisches Institut, Justus-Liebig-Universität Gießen, Gießen, Germany.
Yaser AbdallahPhysiologisches Institut, Justus-Liebig-Universität Gießen, Gießen, Germany.
Csaba CsonkaCardiovascular Research Group, Department of Biochemistry, University of Szeged, Hungary.
Kamilla GömöriCardiovascular Research Group, Department of Biochemistry, University of Szeged, Hungary.
Krisztina KissPharmahungary Group, Szeged, Hungary.
János PálócziPharmahungary Group, Szeged, Hungary.
Judit PipisPharmahungary Group, Szeged, Hungary.
Márta SárközyCardiovascular Research Group, Department of Biochemistry, University of Szeged, Hungary.
Péter FerdinandyPharmahungary Group, Szeged, Hungary.
Rainer SchulzPhysiologisches Institut, Justus-Liebig-Universität Gießen, Gießen, Germany.
Klaus-Dieter SchlüterPhysiologisches Institut, Justus-Liebig-Universität Gießen, Gießen, Germany.
University of Szeged · HUUniversity of Giessen · DESemmelweis University · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIschemic preconditioning (IPC) and ischemic postconditioning (IPoC) are currently among the most efficient strategies protecting the heart against ischemia/reperfusion injury. However, the effect of IPC and IPoC on functional recovery following ischemia/reperfusion is less clear, particularly with regard to the specific receptor-mediated signaling of the postischemic heart. The current article examines the effect of IPC or IPoC on the regulation and coupling of β-adrenergic receptors and their effects on postischemic left ventricular function. METHODS AND

resultsThe β-adrenergic signal transduction was analyzed in 3-month-old Wistar rats for each of the intervention strategies (Sham, ischemia/reperfusion, IPC, IPoC) immediately and 7 days after myocardial infarction. Directly after the infarction a cardioprotective potential was demonstrated for both IPC and IPoC: the infarct size was reduced, apoptosis and production of reactive oxygen species were lowered, and the myocardial tissue was preserved. Seven days after myocardial ischemia, only IPC hearts showed significant functional improvement. Along with a deterioration in fractional shortening, IPoC hearts no longer responded adequately to β-adrenergic stimulation. The stabilization of β-adrenergic receptor kinase-2 via increased phosphorylation of Mdm2 (an E3-ubiquitin ligase) was responsible for desensitization of β-adrenergic receptors and identified as a characteristic specific to IPoC hearts.

conclusionsImmediately after myocardial infarction, rapid and transient activation of β-adrenergic receptor kinase-2 may be an appropriate means to protect the injured heart from excessive stress. In the long term, however, induction and stabilization of β-adrenergic receptor kinase-2, with the resultant loss of positive inotropic function, leads to the functional picture of heart failure.

Indexed as

AnimalsDisease Models, AnimalFemaleIschemic Preconditioning, MyocardialMyocardial Reperfusion InjuryRatsRats, WistarReceptors, Adrenergic, betaVentricular Function, LeftReceptors, Adrenergic, betacardiac remodelingischemic postconditioningischemic preconditioningmyocardial infarctionβ‐adrenergic receptorβ‐adrenergic receptor kinase‐2

Identifiers

PMID29273639
PMCPMC5779008
OpenAlexW2780150428

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.